SPOTLIGHT -
Slideshow
Author(s):
Although the clinical symptoms of psychotic disorders are dramatic and are what most clinicians focus on as their treatment targets, impairments in a wide range of cognitive function are observed in these illnesses.
New NDA Submitted: Bysanti to Treat Acute Bipolar I and Schizophrenia
Treating ‘Morally Objectionable’ Patients
Phase 2 Trial Open Enrollment for SPG302, First Synaptic Regenerative Approach to Treat Schizophrenia
What Will the Future of Alzheimer Disease Treatment Look Like?
In Schizophrenia, Nicotine Enhances Cognitive Performance by Improving Brain Network Function
Are There Sex Differences in Cognition and Does It Matter?